Victrix Investment Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$282K Hold
1,210
– – 0.11% 62
2026
Q2
$256K Sell
1,210
-100
-8% -$19.6K 0.11% 70
2026
Q1
$257K Hold
1,310
– – 0.09% 95
2025
Q4
$227K Hold
1,310
– – 0.09% 97
2025
Q3
$250K Hold
1,310
– – 0.14% 65
2025
Q2
$235K Sell
1,310
-65
-5% -$11.3K 0.1% 96
2025
Q1
$233K Sell
1,375
-225
-14% -$37K 0.12% 91
2024
Q4
$241K Buy
+1,600
New +$249K 0.17% 62

Other funds holding DGX

Victrix Investment Advisors's DGX Position: Q3 2026 in Review

Victrix Investment Advisors held its Quest Diagnostics (DGX) position steady in Q3 2026 at 1,210 shares worth $282K. The position accounts for 0.11% of the portfolio, ranked #62.

Victrix Investment Advisors first reported a position in DGX in Q4 2024 and has held it in 8 quarters since. 75 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Victrix Investment Advisors held 1,210 shares of Quest Diagnostics worth $282K as of Q3 2026.
  • Victrix Investment Advisors left its Quest Diagnostics share count unchanged in Q3 2026.
  • Quest Diagnostics made up 0.11% of Victrix Investment Advisors's portfolio in Q3 2026, its #62 holding.
  • Victrix Investment Advisors first reported a position in Quest Diagnostics in Q4 2024 and has held it in 8 quarters since.
  • 75 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Victrix Investment Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.